Spots Global Cancer Trial Database for Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer

Official Title: Ultra-High Field (7 Tesla) MRI/MRS Evaluation of Breast Cancer

Study ID: NCT01938651

Conditions

Breast Cancer

Interventions

high field strength magnetic resonance imaging

magnetic resonance spectroscopic imaging

chemical exchange saturation transfer magnetic resonance imaging

diffusion-weighted magnetic resonance imaging

dynamic contrast-enhanced magnetic resonance imaging

Study Description

Brief Summary: This pilot clinical trial studies ultra-high field magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) techniques in diagnosing breast cancer. New diagnostic procedures may be a more sensitive way to detect breast cancer.

Detailed Description: PRIMARY OBJECTIVES: I. To implement quantitative dynamic contrast-enhanced (DCE)-MRI, diffusion-weighted (DW)-MRI, 31 phosphorus (31P) MRS, magnetization transfer (MT)-MRI, chemical exchange saturation transfer (CEST)-MRI, and high-resolution structural imaging at 7 Tesla in patients for diagnosing breast tumors. OUTLINE: Patients undergo measurement of tumor perfusion and permeability using DCE-MRI, tumor cellularity using DW-MRI, phospholipid metabolism using 31P MRS, macromolecular content using MT-MRI, and cellular protein content using CEST-MRI. Diagnostic performance of one, or a combination, of these metrics will be investigated in the context of breast cancer.